Birdwatch Note Rating
2024-12-12 17:55:10 UTC - NOT_HELPFUL
Rated by Participant: 7D20312BE4D91B35EC1D48AFD95E3431A43158A87D749716CBDD9C0E872DC8E1
Participant Details
Original Note:
Both notes refer to same source and documents but draw different inferences. The issue remains: obesity rates are higher than 40%. Methods to reduce obesity are GLP-1 or other options like bariatric surgery. GLP-1 high cost and risk of recurrence make it less worthy. https://link.springer.com/article/10.1007/s00464-024-11191-1 https://www.tctmd.com/news/sky-high-cost-sglt2i-and-glp1-agonists-deter-first-line-use https://pubmed.ncbi.nlm.nih.gov/39285034/
All Note Details